B

G

BARLETTA , G

Last name: BARLETTA

First name: G

2024 (v1)

Publication

Metadata-only

Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study

Albertelli, M Rossi, G Nazzari, E

Purpose Immune checkpoint inhibitors (ICPIs) disrupting PD-1/PD-L1 axis have revolutionized the management of advanced non-small cell lung cancer (NSCLC). Some studies identified the development of endocrine toxicity as predictor of better survival in cancer patients treated with ICPIs. The aim of study was to evaluate survival and new onset of...

Uploaded on: July 3, 2024